Medtronic plc has announced the pricing of its €1.5 billion senior notes offering through its wholly-owned indirect subsidiary, Medtronic, Inc. The offering comprises two issuances: €750,000,000 principal amount of 2.950% senior notes due 2030, and €750,000,000 principal amount of 4.200% senior notes due 2045. The proceeds from this offering are intended to repay Medtronic Luxco's senior notes due in 2025. The offering is anticipated to close on September 29, 2025, subject to customary closing conditions. For more details, the full prospectus can be accessed on the U.S. Securities and Exchange Commission website at https://www.sec.gov.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief via PR Newswire (Ref. ID: CG74113) on September 15, 2025, and is solely responsible for the information contained therein.